
NRSN Market Capitalization Overview
Market Cap: $12.75M as of Sep 17, 2026
$12.75M
$247.84M (95.11%)past month
As of Sep 17, 2026, NRSN has a market capitalization of $12.75M. Over the past 30 days, its market cap has increased by —, while in the last 12 months, it has increased by —.
Market capitalization represents the total value of NeuroSense Therapeutics Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
NRSN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of NRSN helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of NeuroSense Therapeutics Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
NRSN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of NRSN helps investors assess the company's size and compare it with competitors for better investment decisions.
NRSN Market Cap & Key Trends
See NeuroSense Therapeutics Ltd’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in NRSN
Order type
Buy in
Order amount
Est. shares
0 shares
NRSN Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Sep 14, 2026 | $260.59M | — |
NRSN End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $12.75M | — |
FAQs About NeuroSense Therapeutics Ltd (NRSN) Market Cap
As of Sep 17, 2026, the market capitalization of NRSN is $12.75M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, NeuroSense Therapeutics Ltd’s market capitalization has decreased by -95.11%, changing from $260.59M to $12.75M as of Sep 17, 2026.
In the last 3 months, NeuroSense Therapeutics Ltd’s market capitalization has increased by —, changing from – to – as of –.
In the year –, NeuroSense Therapeutics Ltd’s market capitalization increased from – in January to – in December, reflecting a — change.